Related Experiment Videos
Peripheral nerve function in patients with chronic bronchitis receiving almitrine or placebo.
Thorax
|April 1, 1989
Summary
Almitrine bismesylate may cause peripheral neuropathy in patients with chronic obstructive pulmonary disease. Early warning signs are crucial for timely drug cessation to prevent nerve damage.
Area of Science:
- Neurology
- Pulmonology
- Pharmacology
Background:
- Chronic bronchitis patients often have arterial hypoxemia.
- Peripheral nerve function can be affected in these patients.
Purpose of the Study:
- To investigate the effect of almitrine bismesylate on peripheral nerve function.
- To assess the risk of peripheral neuropathy in chronic bronchitis patients treated with almitrine.
Main Methods:
- A double-blind, prospective study involving 12 patients with chronic bronchitis and hypoxemia.
- Patients received either almitrine bismesylate or placebo for 12 months.
- Peripheral nerve function was assessed using electrophysiological testing.
Main Results:
- No peripheral neuropathy was observed in the placebo group.
- Four out of five patients receiving almitrine developed symptoms and signs of peripheral neuropathy.
- Electrophysiological studies revealed nerve abnormalities in affected patients, with poor recovery.
Conclusions:
- Almitrine bismesylate may precipitate peripheral neuropathy in patients with chronic obstructive pulmonary disease.
- Patients should be informed about this potential risk for early detection and intervention.